Tumor activated platelets induce vascular mimicry in mesenchymal stem cells and aid metastasis

被引:7
作者
Bhuniya, Avishek [1 ]
Sarkar, Anirban [1 ]
Guha, Aishwarya [1 ]
Choudhury, Pritha Roy [1 ]
Bera, Saurav [1 ]
Sultana, Jasmine [1 ]
Chakravarti, Mohona [1 ]
Dhar, Sukanya [1 ]
Das, Juhina [1 ]
Guha, Ipsita [1 ]
Ganguly, Nilanjan [1 ]
Banerjee, Saptak [1 ]
Bose, Anamika [1 ]
Baral, Rathindranath [1 ]
机构
[1] Chittaranjan Natl Canc Inst, Dept Immunoregulat & Immunodiagnost, 37 SP Mukherjee Rd, Kolkata 700026, India
关键词
Mesenchymal-stem-cells; Platelets; Vascular; -mimicry; Metastasis; E-cadherin; Vimentin; ANGIOGENESIS;
D O I
10.1016/j.cyto.2022.155998
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Extent of metastasis influences activation of platelets in tumor-microenvironment. Activated platelets potentiate mesenchymal-stem-cells (MSCs) to migrate in secondary metastatic sites without participation in process of invasion. Presence of higher percentage of MSCs along with activated-platelets induces formation of vascular -mimicry (VM). The pathophysiology, VM, has already been reported in multiple types of cancer including lung, ovary, melanoma etc. and related to poor-prognosis. Interaction of MSCs with platelets in cell-to-cell contact dependent manner is essential for their migration, thereby, VM. Evidences are obtained suggesting that under influence of tumor-associated-activated-platelets, expressions of vimentin, ve-cadherin are increased, along with decrease in e-cadherin on CD105+ MSCs in both mRNA and protein levels that may help in formation of vessel like structure in VM. Adoptive transfer of MSCs along with tumor-activated-platelets causes greater B16 melanoma metastasis at lungs in comparison to MSCs with non-activated platelets. Presence of CD105+Vimentin+ MSCs in vessel like structure in the metastatic lung confirms the involvement of platelet-activated-MSCs in VM, thereby, in metastasis.
引用
收藏
页数:10
相关论文
共 31 条
[1]   Vascular Mimicry: A Novel Neovascularization Mechanism Driving Anti-Angiogenic Therapy (AAT) Resistance in Glioblastoma [J].
Angara, Kartik ;
Borin, Thaiz F. ;
Arbab, Ali S. .
TRANSLATIONAL ONCOLOGY, 2017, 10 (04) :650-660
[2]   Mechanisms of Vasculogenic Mimicry in Ovarian Cancer [J].
Ayala-Dominguez, Lizbeth ;
Olmedo-Nieya, Leslie ;
Omar Munoz-Bello, J. ;
Contreras-Paredes, Adriana ;
Manzo-Merino, Joaquin ;
Martinez-Ramirez, Imelda ;
Lizano, Marcela .
FRONTIERS IN ONCOLOGY, 2019, 9
[3]   Release of angiogenesis regulatory proteins from platelet alpha granules: modulation of physiologic and pathologic angiogenesis [J].
Battinelli, Elisabeth M. ;
Markens, Beth A. ;
Italiano, Joseph E., Jr. .
BLOOD, 2011, 118 (05) :1359-1369
[4]   The role of platelet activation in tumor metastasis [J].
Borsig, Lubor .
EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (08) :1247-1255
[5]   ZEB2, a master regulator of the epithelial-mesenchymal transition, mediates trophoblast differentiation [J].
DaSilva-Arnold, Sonia C. ;
Kuo, Che-Ying ;
Davra, Viralkumar ;
Remache, Yvonne ;
Kim, Peter C. W. ;
Fisher, John P. ;
Zamudio, Stacy ;
Al-Khan, Abdulla ;
Birge, Raymond B. ;
Illsley, Nicholas P. .
MOLECULAR HUMAN REPRODUCTION, 2019, 25 (02) :61-75
[6]   VE-cadherin promotes vasculogenic mimicry by modulating kaiso-dependent gene expression [J].
Delgado-Bellido, Daniel ;
Fernandez-Cortes, Monica ;
Isabel Rodriguez, Maria ;
Serrano-Saenz, Santiago ;
Carracedo, Arkaitz ;
Garcia-Diaz, Angel ;
Oliver, F. Javier .
CELL DEATH AND DIFFERENTIATION, 2019, 26 (02) :348-361
[7]  
Dunleavey James M, 2012, Curr Angiogenes, V1, P133
[8]   Platelets in wound healing and regenerative medicine [J].
Etulain, Julia .
PLATELETS, 2018, 29 (06) :556-568
[9]   Vasculogenic Mimicry: Become an Endothelial Cell "But Not So Much" [J].
Fernandez-Cortes, Monica ;
Delgado-Bellido, Daniel ;
Javier Oliver, F. .
FRONTIERS IN ONCOLOGY, 2019, 9
[10]   Regulation Networks Driving Vasculogenic Mimicry in Solid Tumors [J].
Hernandez de la Cruz, Olga N. ;
Sullivan Lopez-Gonzalez, Jose ;
Garcia-Vazquez, Raul ;
Salinas-Vera, Yarely M. ;
Muniz-Lino, Marcos A. ;
Aguilar-Cazares, Dolores ;
Lopez-Camarillo, Cesar ;
Carlos-Reyes, Angeles .
FRONTIERS IN ONCOLOGY, 2020, 9